SCHEMBL8606715

SCHEMBL8606715

CC(C)(CCCCCC(=O)O)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER3 P43115 1/20 0.37
▸ PTGER2 P43116 1/20 0.37
▸ SCD O00767 1/20 0.36
▸ PRKCA P17252 1/20 0.36
▸ TBXAS1 P24557 2/20 0.36
▸ CYP4F2 P78329 1/20 0.36
▸ CYP4A11 Q02928 1/20 0.36
▸ IMPDH1 P20839 2/20 0.35
▸ F13A1 P00488 3/20 0.35
▸ TSHR P16473 4/20 0.34
▸ LMNA P02545 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ PPARG P37231 4/20 0.33
▸ PPARD Q03181 4/20 0.33
▸ PPARA Q07869 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17480741 0.88 ACLY (0.44) TBXAS1CYP4F2CYP4A11TSHRPPARG
SCHEMBL23978390 0.85 CYP4F2 (0.41) PRKCACYP4F2CYP4A11TSHRMEN1
SCHEMBL22473554 0.83 F13A1 (0.35) PTGER3PTGER2SCDIMPDH1F13A1
SCHEMBL17377644 0.83 F13A1 (0.35) PTGER3PTGER2SCDIMPDH1F13A1
SCHEMBL20228120 0.82 CYP4F2 (0.36) PRKCACYP4F2CYP4A11TSHRKMT2A
SCHEMBL16372007 0.80 SCD (0.44) SCDTSHRALDH1A1MEN1KMT2A
SCHEMBL18723291 0.80 — —
SCHEMBL25996699 0.79 LTB4R (0.43) TSHRPPARGPPARATDP1
SCHEMBL20365778 0.79 CYP4F2 (0.34) CYP4F2CYP4A11
SCHEMBL12992950 0.79 ELANE (0.41) CYP4F2CYP4A11LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998010638-A1 THERAPEUTIC MOLECULES AMRAD OPERATIONS PTY. LTD. (AU) 1998-03-19 — — WO disclosed
Send feedback